TRINICHROMTM FACTOR VIII:C - COFEPRIS Registration 2192R2019 SSA
Access comprehensive regulatory information for TRINICHROMTM FACTOR VIII:C (TRINICHROMTM FACTOR VIII:C) in the Mexico medical device market through Pure Global AI's free database. This Clase I medical device is registered under COFEPRIS analysis ID 2192R2019 SSA and manufactured by LABORATORIOS LICON, S.A.. The device was registered on November 27, 2019.
This page provides complete registration details including product type (III. DIAGNOSTIC AGENTS), manufacturer information, and regulatory compliance data from the official Mexico COFEPRIS medical device database. Pure Global AI offers free access to Mexico's complete medical device registry with bilingual Spanish/English support, helping global MedTech companies navigate COFEPRIS regulations efficiently.
REACTIVO DISEÑADO PARA LA DETERMINACIÓN CUANTITATIVA DE FACTOR VIII:C EN PLASMA HUMANO Y DE CONCENTRADO DE FACTOR VIII MEDIANTE ENSAYO CROMOGÉNICO. LA DETERMINACIÓN CUANTITATIVA DE FACTOR VIII:C RESULTA ÚTIL EN EL DIAGNÓSTICO DE HEMOFILIA A, ASÍ COMO EN
REAGENT DESIGNED FOR THE QUANTITATIVE DETERMINATION OF FACTOR VIII:C IN HUMAN PLASMA AND FACTOR VIII CONCENTRATE BY CHROMOGENIC ASSAY. QUANTITATIVE DETERMINATION OF FACTOR VIII:C IS USEFUL IN THE DIAGNOSIS OF HEMOPHILIA A, AS WELL AS IN